Aurinia Pharmaceuticals Inc XNAS: AUPH

Strong Performer, Getting Expensive

Download real time

12.31 0.01 (0.08%)

New 52W High in past week

797.5K

XNAS Volume

XNAS 09 Sep, 2025 3:36 PM (EDT)

Aurinia Pharmaceuticals Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents